Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Genetically predicted vitamin D (OR = 0.65, 95% CI: 0.54 to 0.79; p < 0.001, per SD increase) and vitamin K1 (OR = 0.93, 95% CI: 0.90 to 0.97; p = 0.001, per 1‐unit increase in natural logarithm‐transformed) levels were inversely associated with the disease in the meta‐analyses (Figure 2).

Source: The causal role of antioxidants, minerals and vitamins in CD. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Genetic instrumental-variable study.

Genetic instrumental-variable study

Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.

Meta-analysis reported · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Antioxidants, minerals and vitamins in relation to Crohn's disease and ulcerative colitis: A Mendelian randomization study

Source: Article title.

Fixed‐effects meta‐analysis was conducted to combine MR estimates from different data sources.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Antioxidants, minerals and vitamins in relation to Crohn's disease and ulcerative colitis: A Mendelian randomization study

Genetic instrumental-variable study · Alimentary Pharmacology & Therapeutics · 2023

Original publication title

Antioxidants, minerals and vitamins in relation to Crohn's disease and ulcerative colitis: A Mendelian randomization study

Jie Chen; Xixian Ruan; Shuai Yuan; Minzi Deng; Han Zhang; Jing Sun; Lili Yu; Jack Satsangi; Susanna C. Larsson; Evropi Therdoratou; Xiaoyan Wang; Xue Li

© 2023 The Authors. Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our study provided evidence that circulating levels of antioxidants, minerals and vitamins might be causally linked to the development of IBD.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Evidence for antioxidants, minerals and vitamins in relation to the risk of Crohn's disease (CD) and ulcerative colitis (UC) is limited and inconsistent. This mendelian randomization (MR) study aimed to examine the causal associations of circulating levels of antioxidants, minerals and vitamins with CD and UC.

Source: Background

Abstract: What methods does the paper describe?

Single‐nucleotide polymorphisms associated with antioxidants (beta‐carotene, lycopene and uric acid), minerals (copper, calcium, iron, magnesium, phosphorus, zinc and selenium), and vitamins (folate, vitamins A, B6, B12, C, D, E and K1) were employed as instrumental variables. Genetic associations with CD and UC were extracted from the UK Biobank, the FinnGen study and the International Inflammatory Bowel Disease Genetics Consortium. The inverse variance weighted method and sensitivity analyses were performed.

Source: Methods

Abstract: Results

Genetically predicted higher lycopene (OR = 0.94, 95% CI: 0.91 to 0.97), vitamins D (OR = 0.65, 95% CI: 0.54 to 0.79) and K1 (OR = 0.93, 95% CI: 0.90 to 0.97) levels were inversely associated with CD risk, whereas genetically predicted higher magnesium (OR = 1.53, 95% CI: 1.23 to 1.90) levels were positively associated with CD risk. Higher levels of genetically predicted lycopene (OR = 0.91, 95% CI: 0.88 to 0.95), phosphorus (OR = 0.69, 95% CI: 0.58 to 0.82), selenium (OR = 0.91, 95% CI: 0.85 to 0.97), zinc (OR = 0.91, 95% CI: 0.89 to 0.94), folate (OR = 0.71, 95% CI: 0.56 to 0.92) and vitamin E (OR = 0.78, 95% CI: 0.69 to 0.88) were associated with reduced UC risk, whereas genetically predicted high levels of calcium (OR = 1.46, 95% CI: 1.22 to 1.76) and magnesium (OR = 1.24, 95% CI: 1.03 to 1.49) were associated with increased risk of UC.

Source: Results

Abstract: Conclusions

Our study provided evidence that circulating levels of antioxidants, minerals and vitamins might be causally linked to the development of IBD.

Source: Conclusions
Authors’ abstract

Summary

Background

Evidence for antioxidants, minerals and vitamins in relation to the risk of Crohn's disease (CD) and ulcerative colitis (UC) is limited and inconsistent. This mendelian randomization (MR) study aimed to examine the causal associations of circulating levels of antioxidants, minerals and vitamins with CD and UC.

Methods

Single‐nucleotide polymorphisms associated with antioxidants (beta‐carotene, lycopene and uric acid), minerals (copper, calcium, iron, magnesium, phosphorus, zinc and selenium), and vitamins (folate, vitamins A, B6, B12, C, D, E and K1) were employed as instrumental variables. Genetic associations with CD and UC were extracted from the UK Biobank, the FinnGen study and the International Inflammatory Bowel Disease Genetics Consortium. The inverse variance weighted method and sensitivity analyses were performed.

Results

Genetically predicted higher lycopene (OR = 0.94, 95% CI: 0.91 to 0.97), vitamins D (OR = 0.65, 95% CI: 0.54 to 0.79) and K1 (OR = 0.93, 95% CI: 0.90 to 0.97) levels were inversely associated with CD risk, whereas genetically predicted higher magnesium (OR = 1.53, 95% CI: 1.23 to 1.90) levels were positively associated with CD risk. Higher levels of genetically predicted lycopene (OR = 0.91, 95% CI: 0.88 to 0.95), phosphorus (OR = 0.69, 95% CI: 0.58 to 0.82), selenium (OR = 0.91, 95% CI: 0.85 to 0.97), zinc (OR = 0.91, 95% CI: 0.89 to 0.94), folate (OR = 0.71, 95% CI: 0.56 to 0.92) and vitamin E (OR = 0.78, 95% CI: 0.69 to 0.88) were associated with reduced UC risk, whereas genetically predicted high levels of calcium (OR = 1.46, 95% CI: 1.22 to 1.76) and magnesium (OR = 1.24, 95% CI: 1.03 to 1.49) were associated with increased risk of UC.

Conclusions

Our study provided evidence that circulating levels of antioxidants, minerals and vitamins might be causally linked to the development of IBD.

Publication and source details

Original title: Antioxidants, minerals and vitamins in relation to Crohn's disease and ulcerative colitis: A Mendelian randomization study

Jie Chen; Xixian Ruan; Shuai Yuan; Minzi Deng; Han Zhang; Jing Sun; Lili Yu; Jack Satsangi; Susanna C. Larsson; Evropi Therdoratou; Xiaoyan Wang; Xue Li

Alimentary Pharmacology & Therapeutics · 2023

* Correspondence
Xue Li, School of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Email: xueli157@zju.edu.cn
Xiaoyan Wang, Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China.
Email: wangxiaoyan@csu.edu.cn
© 2023 The Authors. Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.CRUK Career Development FellowshipC31250/A22804National Natural Science Foundation of China 10.13039/50110000180981970494Natural Science Fund for Distinguished Young Scholars of Zhejiang Province 10.13039/501100019540LR22H260001Swedish Cancer Society 10.13039/501100002794Swedish Heart Lung Foundation20210351Swedish Research Council 10.13039/5011000043592019‐00977Key Project of Research and Development Plan of Hunan Province 10.13039/1000161042019SK2041

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T20:57:17.941951+00:00

DOI: 10.1111/apt.17392 · PMC11497233